Aura Biosciences grants Person 107,611 RSUs, options
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Aura Biosciences, Inc. (AURA) reported that Chief People Officer Julie Person received 107,611 shares of Common Stock in the form of restricted stock units (RSUs) as an inducement award, and a stock option for 212,389 shares with an exercise price of $7.43 per share.
The RSUs vest in four substantially equal annual installments starting September 15, 2027, conditioned on continued service. The stock option vests 25% on August 12, 2027, with the remaining 75% vesting pro-rata in 36 monthly installments, also subject to continued service, and expires on September 1, 2036.
Insider Trade Summary
Grant/Award: 320,000 shares
Grant/Award
2 txns
Insider
Person Julie
Role
Chief People Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) F2 | 212,389 | $0.00 | $0.00 |
| Grant/Award | Common Stock F1 | 107,611 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 212,389 contracts (Direct);
Common Stock — 107,611 shares (Direct)
Footnotes (2)
- F1. These securities represent an inducement award granted pursuant to a restricted stock unit ("RSU") award agreement with the Issuer. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in four substantially equal annual installments, subject to the Reporting Person's continued service as of the relevant vesting date, with the first tranche scheduled to vest on September 15, 2027.
- F2. The option shall vest as follows: 25% of the options vest on August 12, 2027 with the remainder vesting thereafter pro-rata in 36 monthly installments, subject to the Reporting Person's continued service as of each such vesting date.
Key Figures
RSU shares granted: 107,611 shares
Option shares granted: 212,389 shares
Option exercise price: $7.43 per share
+3 more
6 metrics
RSU shares granted
107,611 shares
Restricted stock unit inducement award to Chief People Officer on September 1, 2026
Option shares granted
212,389 shares
Stock option grant to Chief People Officer on September 1, 2026
Option exercise price
$7.43 per share
Conversion or exercise price for 212,389-share stock option
Option expiration date
September 1, 2036
Expiration date of stock option covering 212,389 shares
Common Stock held after RSU grant
107,611 shares
Direct Common Stock position following RSU inducement award
Underlying Common Stock for option
212,389 shares
Underlying Common Stock associated with reported stock option grant
Key Terms
restricted stock unit ("RSU"), inducement award, vest, pro-rata, +1 more
5 terms
restricted stock unit ("RSU") financial
"These securities represent an inducement award granted pursuant to a restricted stock unit ("RSU") award agreement"
inducement award financial
"These securities represent an inducement award granted pursuant to a restricted stock unit"
An inducement award is a special cash or equity payment given to a new hire—often an executive or key employee—outside the company’s regular pay plans to persuade them to join. Think of it like a signing bonus that can align the new person’s goals with shareholders but also represents a cost and can reduce existing owners’ percentage of the company, so investors watch these awards for their impact on ownership and future performance.
vest financial
"These RSUs vest in four substantially equal annual installments"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
pro-rata financial
"with the remainder vesting thereafter pro-rata in 36 monthly installments"
Pro-rata means an amount is allocated to each party in proportion to their existing share or stake — each person receives the same percentage of the total as they already hold. For investors this matters because pro-rata rules determine how much additional stock, dividends, or voting power someone gets during new issuances or distributions, helping protect an investor’s relative ownership; think of it as slicing a cake so everyone keeps the same-sized slice relative to others.
Stock Option (Right to Buy) financial
"security_title": "Stock Option (Right to Buy)"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What equity awards did AURA grant to Chief People Officer Julie Person?
Julie Person received 107,611 RSUs of Aura Biosciences Common Stock and a stock option for 212,389 shares with an exercise price of $7.43 per share, all reported as direct ownership grants on September 1, 2026.
How do the new RSUs for AURA’s Chief People Officer vest?
The 107,611 RSUs vest in four substantially equal annual installments, subject to continued service, with the first tranche scheduled to vest on September 15, 2027.
What are the vesting terms of the new stock option reported by AURA?
The stock option for 212,389 shares vests 25% on August 12, 2027, with the remaining 75% vesting pro-rata in 36 monthly installments, contingent on Julie Person’s continued service on each vesting date.
What is the exercise price and expiration date of the new AURA stock option?
The reported stock option has an exercise price of $7.43 per share and an expiration date of September 1, 2036, covering 212,389 shares of Aura Biosciences Common Stock.
Are the AURA equity awards to Julie Person part of an inducement arrangement?
Yes. The filing states the 107,611 RSUs are an inducement award granted pursuant to an RSU award agreement, with each RSU representing the right to receive one share of Aura Biosciences Common Stock.
AI-generated analysis. How Rhea-AI works. Not financial advice.
